The PARP-1 Inhibitor Olaparib Causes Retention of γ-H2AX Foci in <i>BRCA</i>1 Heterozygote Cells Following Exposure to Gamma Radiation

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

Journals Menu

"The PARP-1 Inhibitor Olaparib Causes Retention of γ-H2AX Foci in BRCA1 Heterozygote Cells Following Exposure to Gamma Radiation"
written by Emma C. Bourton, Piers N. Plowman, Amanda J. Harvey, Sheba Adam Zahir, Christopher N. Parris,
published by Journal of Cancer Therapy, Vol.4 No.11A, 2013

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	Radiosensitization of clioquinol and zinc in human cancer cell lines
	2018

[2]	The PARP-1 inhibitor Olaparib suppresses BRCA1 protein levels, increases apoptosis and causes radiation hypersensitivity in BRCA1+/-lymphoblastoid cells
	Journal of Cancer, 2017

[3]	Effects of combined treatment with ionizing radiation and the PARP inhibitor olaparib in BRCA mutant and wild type patient-derived pancreatic cancer …
	2016

[4]	Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts
	Gene Therapy, 2016

[5]	Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer …
	PLOS ONE, 2016

[6]	Combined chemo-radiotherapy utilising Olaparib and Mirin in combination with X-rays and targeted radionuclide therapy
	2016

[7]	Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin.
	Chemotherapy (0009 …, 2015

[8]	Enhanced γ‐H2AX DNA damage foci detection using multimagnification and extended depth of field in imaging flow cytometry
	Cytometry Part A, 2015

[9]	Radiosensitivity of Human Breast Cancer Cell Lines Expressing the Breast Tumor Kinase (Brk)
	Journal of Cancer Science & Therapy, 2015

[10]	Embracing synthetic lethality of novel anticancer therapies
	Expert opinion on drug discovery, 2015

[11]	Cancer Science & Therapy
	2015

[12]	Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin
	Chemotherapy, 2014

[1]	Radiosensitization of clioquinol and zinc in human cancer cell lines BMC Cancer, 2018 DOI:10.1186/s12885-018-4264-2

[2]	Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts Gene Therapy, 2016 DOI:10.1038/gt.2016.61

[3]	Embracing synthetic lethality of novel anticancer therapies Expert Opinion on Drug Discovery, 2015 DOI:10.1517/17460441.2015.1072167

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies